(C) 2009 Wiley Periodicals, Inc. J Appl Polym Sci 114: 598-602, 2009″
“Introduction and objectives. At present, little information is available on returning patients with ST-elevation myocardial infarction (STEMI) to their originating centers after find more transfer for primary percutaneous coronary intervention (PPCI). The objective of this study was to evaluate the safety and feasibility of the early return of these patients to their originating centers.
Methods. The cohort study involved 200 consecutive STEMI patients (age 62 13 years, 83% male) who were returned to their originating centers after PPCI. They were compared with a group of 297 patients with
similar characteristics from our healthcare catchment area. The length of stay in the intervention hospital and major adverse cardiovascular events occurring within 30 days were recorded.
Results. The median length of stay in the intervention hospital was 8 hours. No adverse events occurred during transport in the group who returned to their originating centers. At 30-day follow-up, no significant difference was
observed between patients who returned and the control group in either mortality (1.0% vs. 3.7%; P=.064), readmission (5.0% vs. 4.5%; P=.657), ischemic complications (2.5% vs. 2.0%; P=.721), re-catheterization (5.0% vs. 2.5%; P=.112), stroke RG-7388 mw (11 % vs. 1%; P=.936) or the composite end-point (11 % vs. 9.2%; P=.540). Multivariate analysis showed that returning selleck inhibitor patients after PPCI was not associated with a significantly greater number of major adverse cardiovascular events (odds ratio=1.32; 95% confidence interval, 0.62-2.80).
Conclusions. The early return of patients with low-risk STEMI to their originating centers after PPCI was safe and feasible.”
“Possible factors related to seropositivity
and seroconversion to Coxiella burnetii were examined in a dairy herd with a high Coxiella-seroprevalence and high excretion levels of the bacterium in the bulk tank milk. Antibodies were detected by using a commercial ELISA test in 50.7% of 603 parous cows. The likelihood of C. burnetii seropositivity significantly increased by factors of 1.87 and 1.61 for cows in their first and second terms of pregnancy, respectively, compared to non-pregnant cows. In 478 cows tested twice 12 months apart, the seroconversion rate was 5%. The likelihood of C. burnetii-seroconversion was 2.27 times lower in multiparous than in primiparous cows and 6.88 times higher in cows during their first 90 days in milk than dry-off cows. Our findings indicated a higher seroprevalence in the first and second terms of pregnancy, and that seroconversion mainly occurred in primiparous cows during their first 90 days in milk. (C) 2012 Elsevier Ltd. All rights reserved.